Lyell Immunopharma, Inc.
LYEL
$10.64
-$0.33-3.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.10% | -18.72% | -15.89% | -10.30% | -6.68% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -32.21% | -11.76% | -4.54% | 9.11% | 10.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -8.72% | -18.55% | -15.65% | -9.96% | -6.43% |
|
|
|||||
| Total Current Assets | -8.72% | -18.55% | -15.65% | -9.96% | -6.43% |
| Net Property, Plant & Equipment | -11.36% | -7.09% | -41.51% | -4.65% | -4.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.14% | -22.28% | 18.00% | 18.18% | 0.04% |
| Total Assets | -10.32% | -12.44% | -20.73% | -5.34% | -5.77% |
|
|
|||||
| Total Accounts Payable | -9.36% | -30.53% | 49.22% | -14.36% | -14.22% |
| Total Accrued Expenses | -15.01% | -21.92% | 34.24% | 16.53% | 2.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.30% | 3.31% | 11.77% | 3.42% | 3.46% |
| Total Finance Division Other Current Liabilities | -13.52% | -42.35% | 1,121.83% | -10.20% | -60.30% |
| Total Other Current Liabilities | -13.52% | -42.35% | 1,121.83% | -10.20% | -60.30% |
| Total Current Liabilities | -10.61% | -23.24% | 60.50% | 8.53% | -4.56% |
|
|
|||||
| Total Current Liabilities | -10.61% | -23.24% | 60.50% | 8.53% | -4.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.61% | -4.20% | -0.87% | -3.53% | -3.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -3.53% | -3.44% | -8.75% | 3.66% | -3.15% |
| Total Liabilities | -7.23% | -13.66% | 22.05% | 1.00% | -3.76% |
|
|
|||||
| Common Stock & APIC | 0.30% | 0.35% | 2.65% | 0.45% | 0.55% |
| Retained Earnings | -3.05% | -3.88% | -16.64% | -4.02% | -4.31% |
| Treasury Stock & Other | -63.92% | -45.70% | -61.71% | 291.44% | 1.73% |
| Total Common Equity | -11.17% | -12.10% | -27.86% | -6.32% | -6.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.17% | -12.10% | -27.86% | -6.32% | -6.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.17% | -12.10% | -27.86% | -6.32% | -6.08% |
|
|
|||||